Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.

Kwong WJ, Hammond G, Upmalis D, Okamoto A, Yang M, Kavanagh S.

Clin J Pain. 2013 Aug;29(8):664-72. doi: 10.1097/AJP.0b013e318274b695.

PMID:
23835764
[PubMed - indexed for MEDLINE]
2.
3.
4.

Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.

Vorsanger G, Xiang J, Okamoto A, Upmalis D, Moskovitz B.

J Opioid Manag. 2010 May-Jun;6(3):169-79.

PMID:
20642246
[PubMed - indexed for MEDLINE]
5.

Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.

Hale M, Upmalis D, Okamoto A, Lange C, Rauschkolb C.

Curr Med Res Opin. 2009 May;25(5):1095-104. doi: 10.1185/03007990902816970 .

PMID:
19301989
[PubMed - indexed for MEDLINE]
6.

Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride.

Etropolski M, Kelly K, Okamoto A, Rauschkolb C.

Adv Ther. 2011 May;28(5):401-17. doi: 10.1007/s12325-011-0018-0. Epub 2011 Apr 13.

PMID:
21494892
[PubMed - indexed for MEDLINE]
7.

Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.

Biondi D, Xiang J, Benson C, Etropolski M, Moskovitz B, Rauschkolb C.

Pain Physician. 2013 May-Jun;16(3):E237-46.

PMID:
23703422
[PubMed - indexed for MEDLINE]
Free Article
8.

Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.

Kavanagh S, Kwong WJ, Hammond GC, Nelson W, Upmalis D, Yang M.

Pain Med. 2012 Sep;13(9):1110-20. doi: 10.1111/j.1526-4637.2012.01454.x. Epub 2012 Jul 30.

PMID:
22845494
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.

Daniels S, Casson E, Stegmann JU, Oh C, Okamoto A, Rauschkolb C, Upmalis D.

Curr Med Res Opin. 2009 Jun;25(6):1551-61. doi: 10.1185/03007990902952825. Erratum in: Curr Med Res Opin. 2009 Jun;25(6):1561. Dosage error in article text.

PMID:
19445652
[PubMed - indexed for MEDLINE]
10.

The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery .

Stegmann JU, Weber H, Steup A, Okamoto A, Upmalis D, Daniels S.

Curr Med Res Opin. 2008 Nov;24(11):3185-96. doi: 10.1185/03007990802448056 . Epub 2008 Oct 15.

PMID:
18851776
[PubMed - indexed for MEDLINE]
11.

Immediate-release tapentadol or oxycodone for treatment of acute postoperative pain after elective arthroscopic shoulder surgery: a randomized, phase IIIb study.

Vorsanger GJ, Klopfer AM, Xiang J, Benson CJ, Moskovitz BL, Rosenthal NR.

J Opioid Manag. 2013 Jul-Aug;9(4):281-90. doi: 10.5055/jom.2013.0170.

PMID:
24353022
[PubMed - indexed for MEDLINE]
12.

Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies.

Merchant S, Provenzano D, Mody S, Ho KF, Etropolski M.

J Opioid Manag. 2013 Jan-Feb;9(1):51-61. doi: 10.5055/jom.2013.0147.

PMID:
23709304
[PubMed - indexed for MEDLINE]
13.

Comparison of the risks of opioid abuse or dependence between tapentadol and oxycodone: results from a cohort study.

Cepeda MS, Fife D, Ma Q, Ryan PB.

J Pain. 2013 Oct;14(10):1227-41. doi: 10.1016/j.jpain.2013.05.010. Epub 2013 Jul 10.

PMID:
23850177
[PubMed - indexed for MEDLINE]
Free Article
14.

Effect of tapentadol extended release on productivity: results from an analysis combining evidence from multiple sources.

Cepeda MS, Sutton A, Weinstein R, Kim M.

Clin J Pain. 2012 Jan;28(1):8-13. doi: 10.1097/AJP.0b013e3182201983.

PMID:
21646907
[PubMed - indexed for MEDLINE]
15.

Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

Simpson K, Leyendecker P, Hopp M, Müller-Lissner S, Löwenstein O, De Andrés J, Troy Ferrarons J, Bosse B, Krain B, Nichols T, Kremers W, Reimer K.

Curr Med Res Opin. 2008 Dec;24(12):3503-12. doi: 10.1185/03007990802584454 .

PMID:
19032132
[PubMed - indexed for MEDLINE]
16.

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled phase III study.

Afilalo M, Etropolski MS, Kuperwasser B, Kelly K, Okamoto A, Van Hove I, Steup A, Lange B, Rauschkolb C, Haeussler J.

Clin Drug Investig. 2010;30(8):489-505. doi: 10.2165/11533440-000000000-00000.

PMID:
20586515
[PubMed - indexed for MEDLINE]
17.

Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.

Gálvez R, Schäfer M, Hans G, Falke D, Steigerwald I.

Adv Ther. 2013 Mar;30(3):229-59. doi: 10.1007/s12325-013-0015-6. Epub 2013 Mar 7.

PMID:
23475406
[PubMed - indexed for MEDLINE]
18.

Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain.

Frampton JE.

Drugs. 2010 Sep 10;70(13):1719-43. doi: 10.2165/11204470-000000000-00000. Review.

PMID:
20731478
[PubMed - indexed for MEDLINE]
19.

A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans.

Jeong ID, Camilleri M, Shin A, Iturrino J, Boldingh A, Busciglio I, Burton D, Ryks M, Rhoten D, Zinsmeister AR.

Aliment Pharmacol Ther. 2012 May;35(9):1088-96. doi: 10.1111/j.1365-2036.2012.05040.x. Epub 2012 Feb 21.

PMID:
22348605
[PubMed - indexed for MEDLINE]
20.

Effectiveness and tolerability of tapentadol prolonged release compared with prior opioid therapy for the management of severe, chronic osteoarthritis pain.

Steigerwald I, Schenk M, Lahne U, Gebuhr P, Falke D, Hoggart B.

Clin Drug Investig. 2013 Sep;33(9):607-19. doi: 10.1007/s40261-013-0102-0.

PMID:
23912473
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk